MedSurvey

Business Challenge

As medical treatments are becoming more specific, there is an increasing need for more market research to effectively bring new products to market. CAR-T is a novel cancer therapy, so there is a less than clear understanding of it outside of the pharmaceutical and physician worlds. MedSurvey took the additional due diligence of analyzing insurance claims data and found there were far fewer patients and treating physicians than anticipated.

Analytics Solution

Through MedSurvey’s proprietary tools, developed based on years of medical market research experience, in combination with a variety of commercially available databases, the company was able to determine there were fewer patients and physicians involved with CAR-T. MedSurvey was also able to properly identify the type of physician that was administering the treatment. This differed from what was originally anticipated prior to MedSurvey’s analysis of claims-level data and other real-world evidence. With the new understanding of the actual size of the market as presented by MedSurvey and its real-world evidence, survey design shifted from a quantitative methodology to a qualitative methodology to provide a deeper understanding of the original business questions posed by the pharmaceutical company. This precise targeting has aided pharmaceutical companies in making more intelligent and data-driven decisions.

Impact

Oftentimes, health care market research studies are designed around lacking information. Through use of real-world evidence and commercially available databases, MedSurvey has been able to point its clients in the right direction when it comes to designing a market research strategy. This thoughtful approach in sorting out issues in the beginning and arming clients with analytical reports helps to improve methodology and produces better research.